Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Genor Biopharma Holdings Limited ( (HK:6998) ) is now available.
Genor Biopharma Holdings Limited has announced an Extraordinary General Meeting to be held on December 22, 2025, to discuss and potentially approve a proposed merger and a retention plan. The merger involves a specific mandate to issue shares to target shareholders, while the retention plan requires approval under the Takeovers Code. These resolutions, if passed, could significantly impact the company’s strategic direction and shareholder value.
More about Genor Biopharma Holdings Limited
Genor Biopharma Holdings Limited is a company incorporated in the Cayman Islands, focusing on the biopharmaceutical industry. It is listed on the Hong Kong Stock Exchange and is involved in developing and commercializing innovative therapeutics.
Average Trading Volume: 1,188,522
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.75B
For detailed information about 6998 stock, go to TipRanks’ Stock Analysis page.